prtx007
primmune therapeutics
['prtx007', 'immune therap']
primmune therapeutics presents new clinical data from phase 1 study evaluating prtx007 in healthy volunteers at the 2023 american association for cancer research (aacr) annual meeting 
Breaking news from Business Wire